By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Transgenomic said today it has entered into an agreement to raise $3 million in convertible notes.

The Convertible Promissory Note Purchase Agreement was signed with investors associated with life sciences investment firm Third Security. The notes and the equity securities into which the notes can be converted have not been registered, but have been offered and sold in the US pursuant to exemptions from registration requirements, Transgenomic said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.